COVID-19肺部病变所致功能改变——来自多中心V/Q显像登记研究的经验
该研究利用一个纳入9个核医学科、共145例确诊急性SARS-CoV-2感染患者的多中心V/Q SPECT/CT登记数据,按磨玻璃影、碎石路征和实变三种CT病变类型,分别用5分制半定量评分评估通气和灌注受损程度。结果显示,实变最常见且通气受损最重,其次为碎石路征和磨玻璃影,功能损伤多呈反向不匹配或匹配模式。
要点
- 145例中126例(86.9%)可见肺实质病变,实变89例(61.4%)最常见。
- 实变通气评分3.0±0.9最重,碎石路征2.5±1.1次之,磨玻璃影1.7±1最轻。
- 灌注受损以碎石路征和实变为主(均2.1),磨玻璃影较轻(0.9±0.6)。
核心结论
- 在COVID-19患者中,V/Q SPECT/CT显示大比例患者存在肺实质病变并伴通气和灌注损伤。
- COVID-19相关肺部病变按发生频率和功能受损程度依次为实变、碎石路征和磨玻璃影,典型表现为反向不匹配或匹配模式。
研究设计与样本
- 多中心国家登记研究,纳入9个核医学科在确诊急性SARS-CoV-2感染期间完成的V/Q SPECT/CT检查,共145例患者。
- 按胸部CT将COVID-19病变分为磨玻璃影、碎石路征和实变3种基本病变,对每种病变用5分制(0=正常,4=功能缺失)半定量目测评估通气和灌注。
主要发现
- 126例(86.9%)可见肺实质病变;磨玻璃影33例(22.8%),灌注评分0.9±0.6、通气评分1.7±1。
- 碎石路征43例(29.7%),灌注评分2.1±1.1、通气评分2.5±1.1。
- 实变89例(61.4%),灌注评分2.1±1、通气评分3.0±0.9。
关键数值与推荐
- 通气与灌注均采用5分制评分:0=正常,4=功能缺失。
- 磨玻璃影:灌注0.9±0.6、通气1.7±1;碎石路征:灌注2.1±1.1、通气2.5±1.1;实变:灌注2.1±1、通气3.0±0.9。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In coronavirus disease 2019 (COVID-19) patients, clinical manifestations as well as chest CT lesions are variable. Lung scintigraphy allows to assess and compare the regional distribution of ventilation and perfusion throughout the lungs. Our main objective was to describe ventilation and perfusion injury by type of chest CT lesions of COVID-19 infection using V/Q SPECT/CT imaging. PATIENTS AND METHODS: We explored a national registry including V/Q SPECT/CT performed during a proven acute SARS-CoV-2 infection. Chest CT findings of COVID-19 disease were classified in 3 elementary lesions: ground-glass opacities, crazy-paving (CP), and consolidation. For each type of chest CT lesions, a semiquantitative evaluation of ventilation and perfusion was visually performed using a 5-point scale score (0 = normal to 4 = absent function). RESULTS: V/Q SPECT/CT was performed in 145 patients recruited in 9 nuclear medicine departments. Parenchymal lesions were visible in 126 patients (86.9%). Ground-glass opacities were visible in 33 patients (22.8%) and were responsible for minimal perfusion impairment (perfusion score [mean ± SD], 0.9 ± 0.6) and moderate ventilation impairment (ventilation score, 1.7 ± 1); CP was visible in 43 patients (29.7%) and caused moderate perfusion impairment (2.1 ± 1.1) and moderate-to-severe ventilation impairment (2.5 ± 1.1); consolidation was visible in 89 patients (61.4%) and was associated with moderate perfusion impairment (2.1 ± 1) and severe ventilation impairment (3.0 ± 0.9). CONCLUSIONS: In COVID-19 patients assessed with V/Q SPECT/CT, a large proportion demonstrated parenchymal lung lesions on CT, responsible for ventilation and perfusion injury. COVID-19-related pulmonary lesions were, in order of frequency and functional impairment, consolidations, CP, and ground-glass opacity, with typically a reverse mismatched or matched pattern.
引用
- Bonnefoy PB, Bahloul A, Denizot B, et al. Functional Alterations Due to COVID-19 Lung Lesions-Lessons From a Multicenter V/Q Scan-Based Registry. Clin Nucl Med. 2022. PMID: 35605049. doi:10.1097/RLU.0000000000004261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。